Search alternatives:
"significant correlation decrease" » "significantly correlated decrease" (Expand Search), "significant correlation increases" (Expand Search), "significant correlation degree" (Expand Search), "significant competition decreases" (Expand Search)
"significant increased release" » "significant increase release" (Expand Search), "significant increases release" (Expand Search), "significantly increased release" (Expand Search), "significant increased reliance" (Expand Search), "significant increased relative" (Expand Search), "significant increased levels" (Expand Search)
"significant correlation decrease" » "significantly correlated decrease" (Expand Search), "significant correlation increases" (Expand Search), "significant correlation degree" (Expand Search), "significant competition decreases" (Expand Search)
"significant increased release" » "significant increase release" (Expand Search), "significant increases release" (Expand Search), "significantly increased release" (Expand Search), "significant increased reliance" (Expand Search), "significant increased relative" (Expand Search), "significant increased levels" (Expand Search)
-
1
The relationship between N1 and CP separation in Learners.
Published 2019“…<b>Right:</b> Scatter plot for the significant correlation: Decreased N1 amplitude (peaks that were less negative) predicted an increase in between-category distance.…”
-
2
Image_1_In vitro evaluation of iron oxide nanoparticle-induced thromboinflammatory response using a combined human whole blood and endothelial cell model.pdf
Published 2023“…Furthermore, IONPs mediated a strong thromboinflammatory response, as seen by the significantly increased release of 21 of the 27 analyzed cytokines (p<0.05). …”
-
3
Image_2_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
4
Image_4_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
5
Image_1_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
6
Table_1_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.docx
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
7
Image_3_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.tif
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”
-
8
Table_2_IDO1 Inhibition Reduces Immune Cell Exclusion Through Inducing Cell Migration While PD-1 Blockage Increases IL-6 and -8 Secretion From T Cells in Head and Neck Cancer.docx
Published 2022“…Nivolumab significantly increased release of MIP1-α, IL-6, and IL-8 from NK, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells, respectively.…”